The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
The PIPE offering consists of 36,190,476 units
The company has withdrawn all litigation against Vikas Lifecare Limited post withdrawal of the Alwar Case by VLL
The company anticipates 2025 worldwide sales to be between $64.1 billion and $65.6 billion
He also laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB)
The biosimilar Ustekinumab has been developed and manufactured by the company
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
Karkinos is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer.
Subscribe To Our Newsletter & Stay Updated
